Showing results (551-560 of 583) with videos related to
Sort By:
Pageof 59
Pediatrics|August 28, 2021
An Integrated Primary Care Initiative for Child Health in Northern TogoKevin P Fiori, Molly E Lauria, Amanda W Singer, et al.The ISME Journal|November 23, 2019
Function-driven single-cell genomics uncovers cellulose-degrading bacteria from the rare biosphereDevin F R Doud, Robert M Bowers, Frederik Schulz, et al.Metabolic Engineering|October 17, 2025
Feedstock-efficient conversion through hydrogen and formate-driven metabolism in Escherichia coliRobert L Bertrand, Justin Panich, Aidan E Cowan, et al.Metabolic Engineering Communications|September 23, 2020
Adaptive laboratory evolution of Pseudomonas putida KT2440 improves p-coumaric and ferulic acid catabolism and toleranceElsayed T Mohamed, Allison Z Werner, Davinia Salvachúa, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|April 1, 1998
Comparative carcinogenicity in Sprague-Dawley rats of the polychlorinated biphenyl mixtures Aroclors 1016, 1242, 1254, and 1260B A Mayes, E E McConnell, B H Neal, et al.Proceedings of the National Academy of Sciences of the United States of America|June 25, 2021
The F-box protein gene exo-1 is a target for reverse engineering enzyme hypersecretion in filamentous fungiRaphael Gabriel, Nils Thieme, Qian Liu, et al.Biotechnology for Biofuels|November 24, 2017
Xylose induces cellulase production in Thermoascus aurantiacusTimo Schuerg, Jan-Philip Prahl, Raphael Gabriel, et al.Metabolic Engineering|November 22, 2020
Machine learning for metabolic engineering: A reviewChristopher E Lawson, Jose Manuel Martí, Tijana Radivojevic, et al.Leukemia|May 11, 2018
Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypesMona M Hosseini, Stephen E Kurtz, Sherif Abdelhamed, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2008
Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancerCorey J Langer, Kenneth J O'Byrne, Mark A Socinski, et al.Pageof 59